- Filed
- Apr 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 17, 2026 | 976.03K sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 930.73K sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 927.91K sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 922.86K sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 919.87K sh |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $420.43K |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $413.1K |
| Capex | Q2 2026 · Mar 31, 2026 | $9.33M |
| Capex | Q2 2026 · Mar 31, 2025 | $6.45M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $2.01M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$5.45M |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $5.51M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $5.47M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $643.06K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $744.61K |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $685.85K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $672.79K |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $112.37M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $113.07M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $110.95M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $112.09M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $241.18M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $239.5M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $394.47M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $391.09M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $392M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$2.34 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$1.49 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$1.72 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | −$1.35 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$2.34 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$1.49 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$1.72 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | −$1.35 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $41.38M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $82.98M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $40.11M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $80.7M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$2.17M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$1.38M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$1.59M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$1.24M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$384.72K |
| Operating Income | Q2 2026 · Mar 31, 2026 | $3.56M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $461.91K |
| Operating Income | Q2 2026 · Mar 31, 2025 | $4.13M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $43.49M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $91.54M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $43.03M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $89.92M |